Hardy Diagnostics Unveils Chromogenic Biplate to Detect Healthcare-Associated Infections
Hardy Diagnostics unveiled a chromogenic biplate designed to help detect and identify CRE and ESBL producing bacteria.
Hardy Diagnostics unveiled a chromogenic biplate designed to help detect and identify CRE and ESBL producing bacteria.
The company will receive funding to provide the breath biopsy component of a research initiative designed to provide new insights into the mechanisms of response and nonresponse to treatment for seven immune-mediated diseases.
The study results point to the value of liquid biopsies as a noninvasive approach to genotyping and monitoring in patients diagnosed with advanced forms of cancer.
The new diagnostic test enables antibiotic resistance testing and stewardship in gonorrhea treatment.
Read MoreLaboratory monitoring supports compliance with medically assisted opioid addiction treatment using buprenorphine
Read MoreClinical laboratories continue to play a vital role when it comes to diabetes diagnosis.
Read MoreOn a variety of lab and POC platforms, HbA1c testing is playing an increasingly important role.
Read MoreSome argue that cytology adds little to cervical screening efforts, prompting additional discussion on the contribution of cytology to screening protocols.
Read MoreOffered as a laboratory-developed test through a certified laboratory affiliate, the test provides ordering physicians with highly accurate results in hours.
Read MoreBeckman’s Early Sepsis Indicator is a first-of-its-kind, hematology-based cellular biomarker for identifying patients with sepsis, or those at increased risk of developing sepsis.
Read MoreGenomenon’s cited variants reference database will be publicly available for use in genomic applications via BigQuery, Google Cloud’s big data and machine learning data warehouse.
Read MoreBD’s quality control media for platelet testing have been CE marked and cleared by FDA.
Read MoreLabCorp joins Qiagen ‘Day-One’ lab readiness program designed to deliver precision medicine to patients faster.
Read MoreThe LCD represents a major reimbursement milestone on the company’s path to commercialization in 2019.
Read MoreThe federal law comes with significant cuts to Medicare testing fees, but labs that take steps now will be better able to meet the challenge.
Read MoreNano-Signature Discovery Could Revolutionize Cancer Diagnosis A quick and easy test to...
Read MoreThe test determines kidney glomerular filtration rate with an accuracy close to tracer-based plasma clearance measurements, but with the simplicity of a serum sample test.
Read MoreThe analyzer is designed for rapid basic metabolic testing in emergency departments and other hospital point-of-care settings.
Read More